We combine inflammatory biomarker analysis, advanced lipid profiling, arterial imaging, multi-cancer early detection, and optional genomic testing to map your current health status and biological trajectory—identifying risks 10-20 years before clinical manifestation.
These programs are designed for high-performing individuals, high-risk patients, and anyone seeking data-driven prevention with measurable outcomes—so you remain in control of your biological future.
Comprehensive evaluation integrating BaleDoneen cardiovascular assessment, metabolic profiling (insulin resistance, mitochondrial function), cognitive testing, VO2 max analysis, body composition (DEXA), and personalized protocols for peak performance and resilient aging.
Galleri® liquid biopsy detecting 50+ cancer types via circulating tumor DNA (ctDNA) analysis, Whole-Body MRI (brain-to-pelvis imaging), and targeted screening for patients with genetic risk (BRCA1/2, Lynch syndrome, Li-Fraumeni)—enabling intervention at earliest, most treatable stages.
Comprehensive arterial disease detection using inflammatory biomarkers (hsCRP, Lp-PLA2, MPO), NMR lipid particle analysis, CIMT/CAC imaging, insulin resistance markers (fasting insulin, HOMA-IR, CGM), and microvascular function testing—proven protocols reducing cardiovascular events by up to 98%.
Precision assessment of thyroid function (TSH, Free T3, Reverse T3), sex hormones (testosterone, estrogen, DHEA), cortisol rhythms, and cognitive biomarkers—with evidence-based interventions supporting neuroplasticity, memory, mood stability, and neuroprotection against dementia.
Each assessment begins with understanding your unique risk profile—genetics, biomarkers, imaging, lifestyle—and culminates in a prospective plan of care.
Dr. Mona Shawky translates complex data into practical next steps, with a follow-up cadence that keeps momentum visible and outcomes measurable.
Beyond advanced diagnostics, we provide continuous internal medicine care with physician-led oversight, coordinated specialty referrals, and quarterly biomarker tracking—ensuring early intervention when lab trends shift or symptoms emerge.
The goal: maintain metabolic and cardiovascular health, prevent chronic disease progression, and sustain high-level function with a physician who knows your complete medical history, genetic risks, and health priorities.
Continuous oversight for hypertension, diabetes (Type 1/2), thyroid disorders (hypothyroidism, Hashimoto's), COPD, asthma, and autoimmune conditions—using biomarker-guided therapy adjustments and subspecialty coordination to prevent complications and optimize quality of life.
Precision testing and targeted therapy for insulin resistance, metabolic syndrome, thyroid dysfunction, adrenal fatigue, and sex hormone imbalance—restoring energy, cognitive clarity, body composition, and long-term metabolic health.
Personalized protocols for anti-inflammatory nutrition (Mediterranean, low-glycemic, ketogenic), exercise prescriptions (resistance training, VO2 max optimization), sleep architecture improvement, and stress resilience techniques—designed for sustainability and measurable outcomes.
Annual or biennial cardiovascular (CIMT, CAC), metabolic (insulin, HbA1c), hormonal (thyroid, sex hormones), and cancer screening (colonoscopy, mammography, Galleri®, WBMRI) calibrated to your age, genetics, and biomarker trajectory—staying ahead of disease.
Whether you need an executive health optimization program, multi-cancer early detection, or comprehensive cardiovascular and metabolic screening—Lake Washington Internal Medicine offers world-class diagnostics, expert interpretation, and evidence-based action plans that detect disease early and prevent progression.
